Scopio Labs is a startup that operates in the medical technology sector, specifically in the field of digital cell morphology. The company has developed a revolutionary digital imaging technology that allows lab teams, hematopathologists, and clinicians to view cells at an unprecedented resolution of 100X. This full-field imaging technology provides a complete picture of cells, which is crucial for confident clinical decision-making.

Scopio's technology is not just about viewing cells; it also offers a new way of working. The company's end-to-end workflow solutions bring cell morphology into the digital era, providing transformative tools and clinical applications supported by a decision support system. This technology accelerates the review process, improves team capacity, and creates new workflow efficiencies.

One of the key applications of Scopio's technology is in the analysis of Peripheral Blood Smears (PBS). The company's technology allows for a full differential on a PBS without sacrificing the full field of view. It also supports White Blood Cell differentials, Red Blood Cell morphology evaluation, and platelet estimations more consistently and with a 60% improvement in workflow efficiency.

Scopio's business model is likely based on selling its digital imaging technology and software solutions to hospitals and medical labs. The company may also generate revenue from providing ongoing support and updates for its software.

In summary, Scopio Labs is a med-tech startup that uses computational photography to revolutionize the way cells are viewed and analyzed, improving efficiency and accuracy in clinical decision-making.

Keywords: Scopio Labs, digital cell morphology, full-field imaging, computational photography, medical technology, workflow solutions, clinical decision-making, Peripheral Blood Smears, digital imaging technology, med-tech startup.